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Available online 14 November 2015Cognitive impairment is as an important feature of Multiple Sclerosis (MS), and might be even more relevant to
patients than mobility restrictions. Compared to the multitude of studies investigating memory deﬁcits or basic
cognitive slowing, executive dysfunction is a rarely studied cognitive domain in MS, and its neural correlates re-
main largely unexplored. Even rarer are topological studies on speciﬁc cognitive functions in MS. Here we used
several structural MRI parameters – including cortical thinning and T2 lesion load – to investigate neural corre-
lates of executive dysfunction, both on a global and a regional level bymeans of voxel- and vertex-wise analyses.
Forty-eight patientswith relapsing-remittingMS and48healthy controls participated in the study. Five executive
functions were assessed, i.e. verbal and ﬁgural ﬂuency, working memory, interference control and set shifting.
Patients scored lower than controls in verbal andﬁguralﬂuencyonly, and displayedwidespread cortical thinning.
On a global level, cortical thickness independently predicted verbal ﬂuency performance, when controlling for le-
sion volume and central brain atrophy estimates. On a regional level, cortical thinning in the anterior cingulate
region correlatedwith deﬁcits in verbal andﬁguralﬂuency and did so in a lateralisedmanner: Left-sided thinning
was related to reduced verbal – but not ﬁgural – ﬂuency, whereas the opposite pattern was observed for right-
sided thinning. We conclude that executive dysfunction in MS patients can speciﬁcally affect verbal and ﬁgural
ﬂuency. The observed lateralised clinico-anatomical correlation has previously been described in brain-
damaged patients with large focal lesions only, for example after stroke. Based on focal grey matter atrophy,
we here show for the ﬁrst time comparable lateralised ﬁndings in a white matter disease with widespread
pathology.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Multiple Sclerosis (MS) is a chronic demyelinating disease affecting
all parts of the central nervous system. It used to be characterisedFDR, false discovery rate; FLAIR,
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icle width; VLSM, voxel-lesion
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. This is an open access article underprimarily by its sensory, motor and visual symptoms. However, cogni-
tive impairment is now recognised as an important feature of MS, prev-
alent in 43–70% of patients (Chiaravalloti and DeLuca, 2008). It might
even be more relevant to patients than mobility restrictions (Amato
et al., 2006). As MS has usually an early onset in young adult life
(Calabrese, 2006), cognitive impairment signiﬁcantly contributes to pa-
tients' disability status, is critical for working capacity, and thus nega-
tively affects quality of life (Rao et al., 1991). Processing speed and
episodic memory seem the most prominent cognitive features of MS
(Chiaravalloti and DeLuca, 2008); however, MS patients often exhibit
signiﬁcant deﬁcits in executive functions too (Drew et al., 2008). Al-
though the latter can have devastating effects on patients' everyday
life, their level of independence and societal costs (Amato et al., 2013),
studies examining executive deﬁcits in MS patients are relatively rare
(Foong et al., 1997; Henry and Beatty, 2006; Radomski et al., 2015),the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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basic cognitive slowing (e.g. Chiaravalloti and DeLuca, 2008; Rogers
and Panegyres, 2007; Roth et al., 2015). Traditionally, MS has been
thought of as a white matter disease, with focal demyelinating lesions
in the white matter being the pathological hallmark. However, this
view has been challenged in recent years. It is now known that grey
matter areas including the cerebral cortex can also be affected
(Calabrese et al., 2012), a ﬁnding demonstrated ﬁrst in post-mortem
analyses (Kidd et al., 1999). In addition to focal lesions, brains of MS pa-
tients sometimes show considerable atrophy (Barkhof, 2002), which af-
fects not only white, but also grey matter structures. Atrophy can
become manifest, for example, as widespread cortical thickness reduc-
tion, with a predominant involvement of temporal and frontal regions
(Calabrese et al., 2010; Narayana et al., 2013; Sailer et al., 2003).
Modern MRI techniques and post-processing methods assessing at-
rophy parameters contribute to the improvement in understanding the
mechanisms responsible for physical and cognitive impairment in MS
(Filippi and Rocca, 2010). During the last three decades, many studies
have demonstrated an association between white matter pathology
and cognitive impairment (e.g. Rao et al., 1989). However, only modest
correlationswere found (e.g. Foong et al., 1997; Swirsky-Sacchetti et al.,
1992), so that amajority of variance in cognitive performance remained
unexplained. MRI markers of atrophy such as increased third ventricle
width or reduced total white and grey matter volumes are consistently
found to correlate more strongly with cognitive deﬁcits (Amato et al.,
2004; Benedict et al., 2006) thanwhitematter lesion load. In the last de-
cade, grey matter pathology, i.e. cortical and deep grey matter atrophy
and cortical lesion load, has been identiﬁed as a signiﬁcant substrate
of cognitive impairment, by showing particularly strong associations
(e.g. Amato et al., 2004; Calabrese et al., 2009; Nielsen et al., 2013;
Zivadinov et al., 2001).
Despite the huge amount of correlation studies between different
structural alterations and cognitive dysfunction inMS, focal–topological
studies on speciﬁc cognitive functions are rare. For example, deﬁcits in
sustained attention and working memory were related to lesions in
bilateral frontal and parietal white matter (Sperling et al., 2001), and
deﬁcits in verbal learning to lesions in the left frontal lobe (Reuter
et al., 2011). With regard to atrophy, bilateral hippocampal atrophy
has been related to impaired verbal learning (Sicotte et al., 2008).
The aim of the present study was to investigate executive dysfunc-
tion in patients withMS and to analyse its relationship with both global
and regional MRI markers. Our methodological focus was on cortical
thinning. Only few previous studies have addressed the identiﬁcation
of cortical thinning in MS and its association to global cognitive impair-
ment (Calabrese et al., 2010; Morgen et al., 2006; Tekok-Kilic et al.,
2007). And to thebest of our knowledge, only a single study so far inves-
tigated the impact of regional cortical thinning on speciﬁc cognitive dis-
ability, showing that focal thinning in the bilateral fusiform gyrus was
related to impaired processing of facial expressions (Mike et al., 2013).
Here we extend this approach by examining whether similar foci can
be found for MS-related executive dysfunction.
2. Materials and methods
2.1. Participants
Forty-eight patients with a deﬁnite diagnosis of MS according to the
McDonald 2010 criteria (Polman et al., 2011) and a relapsing–remitting
course were recruited at the Multiple Sclerosis Centre of the University
Hospital of Zurich. Forty-seven patients (98%) were treated with an
immunomodulatory drug — 32 with natalizumab, ten with beta-
interferons, three with ﬁngolimod, one with glatiramer acetat, one
with dimethylfumarate, and one patient had no disease-modifying
therapy. We applied the following exclusion criteria: a) relapse or
steroid-treatment during the last two months, b) current or past
neurological disorder in addition to multiple sclerosis, c) psychiatricdisorder apart from multiple sclerosis-related depressive mood
state, d) a reading-relevant visual acuity deﬁcit, e) a writing- and/or
drawing-relevant upper limb sensorimotor impairment of the
dominant hand and f) dysarthria. Furthermore, 48 age-, gender-,
handedness-, and education-matched healthy controls without pre-
vious or present history of neurological or psychiatric dysfunction
were included. The study was approved by the regional Ethics
Committee. All participants providedwritten informed consent. Control
participants received ﬁnancial compensation for their attendance.
2.2. Neuropsychological and neurological examination
Neuropsychological and neurological (only for the patient group)
examinations were performed within one month of the MRI scan de-
scribed below by experienced clinicians of theMultiple Sclerosis Centre.
Five executive functions were examined. First, verbal-phonematic
ﬂuency was assessed with the Regensburger verbal ﬂuency test
(Aschenbrenner et al., 2000). Participants were required to generate
as many words as possible beginning with the letter “s” in two
minutes. Repetitions of word stems or deviations from test rules
were regarded as errors; the number of correct answers was further
analysed. The HAMASCH-ﬁve-points-test (Haid et al., 2002) was ap-
plied to assess ﬁgural ﬂuency (Regard et al., 1982). This test required
participants to create as many unique designs as possible through
connecting at least two dots of a ﬁve-dot pattern with straight lines
within three minutes. The total number of unique designs entered
further analyses. Furthermore, working memory was assessed by a
two-back task (Zimmermann and Fimm, 2007), where the total
number of errors (number of misses plus number of false positives)
was further analysed. The Colour-Word-Interference subtest of the
Delis–Kaplan Executive Function System (Delis et al., 2001) was
used to investigate response inhibition and set shifting. In the inter-
ference condition, participants had to name the colour of the ink in
which the word was printed – which is at conﬂict with the word
meaning – while inhibiting the propensity to read the word. In the
switching condition, participants had to irregularly alternate between
reading the word and naming the ink, depending on the presence or ab-
sence of a box surrounding the word. Again, ink colour and word mean-
ing were always at conﬂict with one another. Furthermore, a third
condition of the D-KEFS colour-word interference test, i.e. the colour
naming condition, served as a control parameter for basic information
processing speed. As this study focuses on executive functions rather
than on basic cognitive slowing, corrected time-to-completion indices
were calculated with this latter parameter, according to the procedure
speciﬁed by Delis and colleagues (2001). In other words, and concerning
both interference control and set shifting, two variables entered further
analyses, i.e. the number of correct answers and the corrected
time-to-complete. Moreover, participants had to complete a German
version (Hautzinger and Bailer, 1992) of the CES-D Depression
questionnaire (Radloff, 1977) and the Würzburg Fatigue Inventory
(WEIMuS) (Flachenecker et al., 2008) to self-assess depressive
symptoms as well as cognitive and physical fatigue during the last
week. Similar to other studies (Sumowski et al., 2014), cognitive re-
serve was examined with vocabulary knowledge. In our study, the
Multiple-Choice Word Test-B (Lehrl, 2005) was applied. Additionally,
Expanded Disability Status Scale (EDSS) scores (Kurtzke, 1983) were
obtained in all patients.
2.3. MR image acquisition protocol
All images were acquired with a neuro-optimised 1.5 Tesla MR scan-
ner (SiemensMagnetomAvantoTM) equippedwith a SQ-engine gradient
(45m/T/m@ 200 T/m/s) using a dedicated 32-channel head coil. The se-
quences acquired in each subject included a T1-weighted Magnetisation
Prepared Rapid Gradient Echo (MPRAGE; voxel size=1 x 1 x 1mm, slice
thickness = 1 mm, repetition time = 2420 ms, echo time = 4.18 ms,
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Recovery sequence (FLAIR; voxel size = 0.9 x 0.9 x 2.0 mm, slice
thickness = 2mm, repetition time= 5000ms, echo time= 342ms, in-
version time = 1800 ms).
2.4. Image analysis
2.4.1 . T2-hyperintense lesion volume
FLAIR-hyperintense lesionswere identiﬁed andmanually delineated
with MRIcron (http://sph.sc.edu/comd/rorden/mricron), which was
also used tomeasure total lesion volume. An experienced rater (TP), su-
pervised by a neuroradiologist (BS), performed this lesion analysis. Sta-
tistical Parametric Mapping (SPM8, http://www.ﬁl.ion.ucl.ac.uk/spm/)
was used to co-register and normalise individual lesion maps to MNI
(Montreal Neurological Institute and Hospital) standard space. Normal-
ised lesion maps were then mapped on a template brain with MRIcron
to create lesion overlap plots. Included in the MRIcron package, the
non-parametric mapping software (Rorden et al., 2007) was used to
analyse possible associations of behavioural performance with the spa-
tial distribution of lesions, i.e. voxel-based lesion symptom mapping
(VLSM).
2.4.2 . Central atrophy
Central brain atrophy was examined by measuring the width of the
third ventricle (TVW), applying the procedure speciﬁed by Benedict
and colleagues (Benedict et al., 2006). Accordingly, a line was drawn
through the long axis of the third ventricle parallel to the interhemi-
spheric ﬁssure on the axial MPRAGE slice on which the third ventricle
was best visible. Then a second line, perpendicular to the ﬁrst one,
was drawn through the midpoint of the ﬁrst line and measured with
the Jim software (Xinapse Systems Ltd., Northants (UK); http://www.
xinapse.com).
2.4.3 . Cortical thickness analyses
Cortical thickness evaluation was performed with the Freesurfer
image analysis suite, which is documented and freely available online
(http://surfer.nmr.mgh.harvard.edu). It is a set of automated processing
procedures, requiring 3D MPRAGE MRI images and comprising skull-
stripping, registration, intensity normalisation, Talairach transforma-
tion, tissue segmentation and surface parcellation. Further information
and technical details of the procedures are described in prior publica-
tions (Fischl et al., 1999). To detect possible misclassiﬁcations of white
and grey matter, e.g. due to multiple sclerosis lesions, all images were
visually inspected after the white/grey matter segmentation. In two pa-
tients, a semi-automated correction of topological defects was required
by manually adding control points.
2.5. Statistical analysis
Statistical analyses of the demographic and cognitive data were per-
formed in SPSS (IBM, Chicago, USA, Version, 21.0, http://spss.com). Un-
less otherwise stated, a p-level below 5% was considered statistically
signiﬁcant. Assumptions for normality were tested for all continuous
data with Kolmogorov–Smirnov tests, and parametric (t-test, Pearson
correlation) or non-parametric tests (Mann–Whitney-U, Spearman
rank correlation) were used when appropriate. Chi-Square tests were
conducted to test for differences in frequency distributions between
the two groups. Whole-brain vertex-wise statistical analyses of cortical
thickness were performed with the Query Design Estimate Contrast
(Qdec) module implemented in Freesurfer.
As a ﬁrst step, we analysed signiﬁcant group differences in demo-
graphic variables (age, cognitive reserve, gender, handedness), fatigue,
depressive symptoms, global cortical thickness, third ventricle width,
and executive functions. Further analyses were restricted to those exec-
utive functions for which signiﬁcant impairments were observed. In
order to analyse whole-brain vertex-wise differences in corticalthickness between the two groups a general linear model (GLM) was
used. Key demographics (e.g. age, education) were not controlled for,
as these did not statistically differ between groups. Group differences
of the cortical thickness were separately calculated for each hemi-
sphere. A false discovery rate (FDR) of 0.05 was used to control for mul-
tiple comparisons.
As a next step, we analysed the association of impaired executive
functions with demographic and disease variables (age, disease dura-
tion, EDSS, education, fatigue, depressive symptoms) within the patient
group. Any variable signiﬁcantly associated with executive impairment
were controlled for in subsequent analyses. In a third step, the relative
contribution of global MRI variables on executive performance was ex-
amined by hierarchical regression analyses. Multicollinearity between
MRI variables was assessed using the variance inﬂation factor.
In a ﬁnal step, the relationship between regional structural alter-
ations and executive dysfunction was examined. A general linear
model at each vertex point of the cortical surface model was used to in-
vestigate the correlation between areas of regional cortical thickness
with executive impairment. Statistical surfacemaps showing signiﬁcant
correlations between cortical thinning and executive performancewere
generated by thresholding the images of t-statistics at a 0.05 signiﬁ-
cance level, corrected for FDR. For the VLSM we performed Brunner–
Munzel tests (Brunner and Munzel, 2000) at a threshold of 5% FDR to
identify lesioned voxels associated with executive deﬁcits. Only voxels
affected in at least two patients were considered for analysis. For all
vertex- and voxel-wise analyses, only clusters with a continuous extent
of 10 mm2 were reported.
3. Results
3.1. Demographic, clinical and conventional MRI assessment
Age (p = 0.691), education (p = 0.398), gender (p N 0.99), and
handedness (p = 0.506) did not signiﬁcantly differ between controls
and patients. An overview of the main demographic, clinical and MRI
features of patients and controls is given in Table 1. Lesion probability
maps are shown in Fig. 1, displaying the expected accumulation (Rossi
et al., 2012) of T2-hyperintense lesions in periventricular areas.
3.2. Cognitive ﬁndings
Test and questionnaire results are displayed in Table 2. Cognitive
reserve was nearly identical in the two groups. Performances in the
working memory, response inhibition and set shifting tests did not sig-
niﬁcantly differ between controls and patients (all p N 0.05). However,
differences were found in the number of items generated during
the verbal and ﬁgural ﬂuency tasks (both p b 0.001), with patients
generating fewer items than controls in both tasks. Patients were
signiﬁcantly slower in colour naming condition of the D-KEFS
word-colour-interference test, indicating slowed basic information
processing (p b 0.05). Moreover, patients showed higher levels of
cognitive (p = 0.003) and physical (p b 0.001) fatigue, as well as a
higher level of depressive mood state (p= 0.025), relative to controls.
Verbal and ﬁgural ﬂuency performances were not signiﬁcantly asso-
ciated with age, disease duration, depressive symptoms, and cognitive
or physical fatigue (all p N 0.05). However, our measure of cognitive
reserve was related to verbal ﬂuency (r = 0.298; p = 0.02), while
EDSS scores correlated with ﬁgural ﬂuency performance (r =−0.310;
p= 0.03). Therefore, these two variables were controlled for in further
analyses.
3.3. MRI ﬁndings
Mean global cortical thickness was reduced in multiple sclerosis
patients compared to controls (Table 1; p b 0.001). Whole-brain
vertex-wise analysis revealed multiple brain areas of signiﬁcant cortical
Table 1
Demographic and disease characteristics.
RRMS patients
(n = 48)
Healthy controls
(n = 48)
Z-/t-/Χ2
score
p-Value
Demographics
Age, years (mean, SD) a 38.8 (9.3) 38.0 (9.6) t = 0.398 0.691
Females/males (number) 37/11 37/11 Χ2 = 0.000 N0.999
Years of education (median, range) 13 (11–22) 14 (11–20) Z =−0.846 0.398
Disease duration, years since diagnosis (mean, SD) 6.5 (5.4) n/a n/a n/a
EDSS score (mean, SD) 2.69 (1.9) n/a n/a n/a
MRI metrics
T2- hyperintense lesion volume, cm3 (mean, SD) 8.82 (9.24) n/a n/a n/a
Cortical thickness global, mm (mean, SD) a 2.33 (0.13) 2.42 (0.11) t =−3.435 b0.010⁎⁎
Third ventricle width, mm (median, range) 3.70 (1.2–12.7) 2.40 (1.2–7.4) Z =−4.785 b0.010⁎⁎
Abbreviations: SD = standard deviation
Unless otherwise noted statistical comparisons are based on Mann–Whitney U tests.
a Because of normal distribution in both samples statistical comparisons are based on t-tests.
⁎⁎ p b 0.01.
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controls (Fig. 2). Cortical thinning was spread over broad regions of
both hemispheres. Anatomical locations of clusters of decreased cortical
thickness in the patients are summarised in Supplementary Table 1.
3.4. Global analyses
The hierarchical regression model accounted for 45.7% of the
variance in verbal ﬂuency performance. No predictor indicated
multicollinearity (all variance inﬂation factors b 4). After controlling
for education in block one, lesion volume retained in block two, with
larger lesion volume predicting worse performance in verbal ﬂuency
(R2 = 0.288, p= 0.003). In block three, TVW as an indicator of central
brain atrophy accounted for an additional 7% of variance in verbalﬂuen-
cy performance, with more atrophy predicting worse verbal ﬂuency
performance (R2= 0.364, p=0.026). Finally, in block four global corti-
cal thickness accounted for additional 9% of variance in verbal ﬂuency,
with a thinner cortex being associated with worse verbal ﬂuency
performance (R2=0.457, p=0.010). In other words, cortical thickness
independently predicted verbal ﬂuency, even when controlling for
lesion volume and central brain atrophy estimates. Regarding ﬁgural
ﬂuency, the full hierarchical regression model accounted for 30.2% of
variance in ﬁgural ﬂuency performance. After controlling for EDSS in
block one, there was a negative effect of lesion volume on ﬁgural
ﬂuency (R2 = 0.285, p = 0.009) in block two, but no effect of brain
atrophy (TVW) in block three (p = 0.335) or cortical thinning in
block four (p=0.729).Within the control group, neither global cortical
thickness nor the TVW signiﬁcantly correlated with verbal or ﬁgural
ﬂuency performance (all p N 0.05).
3.5. Regional analyses
Clusters of signiﬁcant correlations between regional cortical thick-
ness and verbal or ﬁgural ﬂuency performance within the patient
group are shown in Fig. 3 and Table 3. Poorer performance in the verbal
ﬂuency task correlated with a thinner cortex within the left anteriorFig. 1. Spatial distribution of T2-hyperintense lesions. All normalised T2-hyperintense lesions o
mulation. Image orientation follows the radiological convention (right on left side). The colourcingulate, superior frontal, lateral orbitofrontal, fusiform and superior
parietal region. These clusters survived FDR-correction. Performance
in the ﬁgural ﬂuency task was associated with cortical thickness in the
right anterior cingulate and insula. No signiﬁcant correlations were ob-
served in the control group. Concerning the relation of T2-hyperintense
lesion location with ﬂuency, VLSM revealed no clusters of lesioned
voxels associated with performance in the two ﬂuency tasks.
4. Discussion
The results of the present study indicate that executive dysfunction
in patients with multiple sclerosis can speciﬁcally affect verbal and
ﬁgural ﬂuency. For both deﬁcits, side- and site-speciﬁc cortical corre-
lates in the anterior cingulate region were found by means of cortical
thickness analysis. Although several clusters of cortical thinning were
associated with verbal and ﬁgural ﬂuency, only one of them was con-
gruent across the two hemispheres, i.e. the one in the anterior cingulate
cortex. The main ﬁnding of the present study is the lateralized charac-
teristic of the correlational analyses: Thinning in the left anterior
cingulate cortex predicted verbal – but not ﬁgural – ﬂuency, while the
opposite pattern was found for thinning in the right anterior cingulate
cortex. This lateralisation corresponds well with lesion studies in
patients with focal brain damage linking verbal ﬂuency with the left
prefrontal cortex and ﬁgural ﬂuency with the right prefrontal cortex
(Robinson et al., 2012; Schwartz and Baldo, 2001). These studies were
based on patients with relatively large focal lesions, for example due
to stroke or brain tumours. On the basis of focal grey matter atrophy,
our study demonstrates the same lateralised clinico-anatomical correla-
tion pattern in MS, which is traditionally seen as a white matter disease
with widespread pathology.
Previous studies showed that tests of verbal ﬂuency are amongst the
most sensitive neuropsychological instruments to assess cognitive im-
pairment in multiple sclerosis, relative to other measures of executive
functioning (Henry and Beatty, 2006). Fluency tasks in general have a
long tradition in the examination of one of the most important execu-
tive function, i.e. the voluntary generation of new series of responses.f all patients are shown in the lesion maps, illustrating pronounced periventricular accu-
bar indicates the number of overlapping lesions.
Table 2
Neuropsychological test and questionnaire results.
RRMS patients Healthy controls t-/Z-Score p-Value
Executive functions
Verbal ﬂuency, no. correct (median, range) 18.5 (9–34) 25 (15–45) Z =−4.821 b0.010⁎⁎
Figural ﬂuency, no. correct (mean, SD) a 32.42 (8.3) 43.23 (8.6) t =−6.266 b0.010⁎⁎
Working memory, errors total (median, range) 3.0 (0–16) 2.0 (0–11) Z =−1.611 0.107
Response inhibition, hits (median, range) 49 (43–50) 50 (45–50) Z =−1.805 0.071
Response inhibition, corrected time-to-complete (median, range) 1 1 (−3–5) 1 (−8–5) Z =−1.268 0.205
Set shifting, hits (median, range) 49.0 (41–50) 49 (45–50) Z =−0.756 0.450
Set shifting, corrected time-to-complete (median, range) 2 0 (−6–5) 0 (−7–5) Z =−1.024 0.306
Questionnaires
Cognitive fatigue (median, range) 5.5 (0–30) 2.0 (0–21) Z =−3.216 b0.010⁎⁎
Physical fatigue (median, range) 6.0 (0–15) 1.5 (0–32) Z =−3.005 b0.010⁎⁎
Total fatigue (median, range) 13.5 (0–55) 4.0 (0–36) Z =−3.332 b0.010⁎⁎
Depressive symptoms (median, range) 9.0 (0–37) 6.5 (0–23) Z =−2.243 0.025⁎
Cognitive reserve
MWT-B (median, range) 30.5 (23–37) 31.0 (25–36) Z =−0.589 0.556
Abbreviations: MWT-B =Multiple-Choice Word Test-B; SD = Standard deviation.
Unless otherwise noted statistical comparisons are based on Mann–Whitney U tests.
a Because of normal distribution in both samples statistical comparisons are based on t-tests.
⁎ p b 0.05.
⁎⁎ p b 0.01.
1 Here, corrected time-to-complete means the difference of the scaled scores between the interference condition and the basic colour naming condition, as proposed by Delis et al.
(2001).
2 Here, corrected time-to-complete means the difference of the scaled scores between the interference condition and set shifting condition.
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generate non-overlearned responses for all types of ﬂuency tasks
(Robinson et al., 2012). Performance deﬁcits on ﬂuency tasks are due
to a failure of “energisation” (Stuss and Alexander, 2007), that is, the
process of initiating and sustaining any response, which is required for
the generation of new responses.
In this framework, the ﬂuency deﬁcits found in the present study
could be re-labelled “cognitive hypoenergisation”. It might be tempting
to view this latter concept as identical to that of cognitive fatigue.
However, in line with previous studies showing that self-reported
fatigue is not associated with cognitive deﬁcits in multiple sclerosis
(Morrow et al., 2009), we did not ﬁnd a signiﬁcant correlation
between ﬂuency performance and self-reported cognitive fatigue in
our patient sample.
Patients with large medial frontal lobe lesions that involve the
cingulate cortex often show deﬁcits in spontaneous initiation of speech
and movement and/or an inability to suppress externally triggered
subroutines (Paus, 2001). Akinetic mutism, which is caused by bilateral
medial frontal lesions, represents an extreme example of this clinico-Fig. 2.Differences in cortical thickness. Statisticalmaps representing signiﬁcant cortical thicknes
inﬂated brains. A colour scale indicates statistical signiﬁcance and shows p-values. Red/yellowanatomical association (Barris and Schuman, 1953). Robinson and col-
leagues (Robinson et al., 2012) conclude that energisation processes –
necessary for ﬂuency tasks – are bilaterally represented in the medial
frontal region. To the best of our knowledge, we here show for the
ﬁrst time that the relation between anterior cingulate pathology and
hypoenergetic cognitive functioning can also be found in patients with
multiple sclerosis.
With regard to the clinical assessment of executive functions inmul-
tiple sclerosis, we propose that the inclusion of ﬂuency tasks is particu-
larly relevant. These brief tests are sensitive to executive impairment
and – as suggested by our ﬁndings – cortical involvement, providing cli-
nicians' efﬁcient tools in situations when examination time is limited.
Comparable to previous studies, we could only ﬁndmodest associa-
tion between T2-hyperintense lesion burden and cognitive test perfor-
mance. Roosendaal and colleagues (2009) suggest that onemain reason
of this is that pathology outside the focal whitematter lesions, in the so-
called normal appearing white matter (NAWM), remains largely unde-
tected by conventional MRI. By now, there is evidence that advanced
MRI sequences, such as diffusion tensor imaging (DTI) exhibit mores differences between patients and controls on lateral,medial, inferior and superior viewof
areas represent clusters of signiﬁcant cortical thinning in patients, relative to controls.
Fig. 3.Association of cortical thickness andﬂuency performance. Correlation ofﬂuency performance and cortical thicknesswithin patients. On the left side, statisticalmaps showclusters of
signiﬁcant correlation between verbal (A) and ﬁgural (B)ﬂuency performance and cortical thickness in the patient groups. On the right side, scatterplots illustrate the correlation between
cortical thickness in the anterior cingulate cortex cluster and verbal (A), respectively ﬂuency (B) performance.
94 O. Geisseler et al. / NeuroImage: Clinical 10 (2016) 89–95robust relationship with cognitive variables (e.g. Roosendaal et al.,
2009; Van Hecke et al., 2010), as it provides in-vivo information about
the orientation and integrity of WM ﬁbre bundles. Thus, NAWM chang-
es should be investigated as an additional mechanism related to cogni-
tive dysfunction beside T2-hyperintense lesion volume, central and
cortical atrophy. Furthermore, DTI – potentially in combination with
fMRI – would allow analyses of neuroconnectivity and neuronal net-
works. As cognitive functions and thus also ﬂuency performances are
likely based on a network of brain regions – rather than on a single re-
gion – additional knowledge could be gained with such analyses. Based
on previous and our ﬁndings, we propose that the AC is an important
node of the ﬂuency network.
The present study is not without limitations: First, only MS patients
suffering from the relapsing-remitting subtype were included, so that
the generalisation of the ﬁndings to other forms of multiple sclerosis
such as the primary progressive variant is debatable. Furthermore, the
cross-sectional design of the study does not allow causal interpretationTable 3
Regions of cortical thinning signiﬁcantly associated with verbal and ﬁgural ﬂuency in the
patient group.
Cluster
number
Talairach
coordinates
x, y, z
Surface extension
(mm2)
-log
(p)
Structures
Left hemisphere, medial surface
Verbal ﬂuency
1 −35.5, 17.1,−19.6 109.6 5.412 Fusiform
2 −10.5, 52.3, 9.6 50.75 4.999 Superior frontal
3 −14.2, 23.8,−16.4 85.84 4.956 Lateral orbitofrontal
4 −34.0,-48.4,−10.2 58.35 4.739 Fusiform
5 −8.3, 21.8, 27.9 44.60 5.676 Caudal anterior
cingulate
Right hemisphere, medial and lateral surfaces
Figural ﬂuency
1 13.1, 10.6, 37.3 46.01 5.386 Anterior cingulate
2 34.1, 3.3, 7.6 17.61 4.664 Insula
All p-values corrected formultiple comparisonusing FDR=0.05. Small signiﬁcant clusters
are not shown (Cluster size b 10 mm2). Anatomical terms are used according to the
Desikan–Killiany template.of the observed association between structural MRI changes and cogni-
tive impairment.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2015.11.008.
Conﬂict of Interest
ML received grants, funding or honoraria from Bayer, Biogen,
Genzyme, Merck, Novartis and Teva. The other authors declare that
they have no conﬂict of interest.
Acknowledgment
This workwas supported by the SwissMultiple Sclerosis Society and
Bayer Switzerland (Bseva/SGSZJX313B21/6890000).
References
Amato, M., Bartolozzi, M., Zipoli, V., Portaccio, E., Mortilla, M., Guidi, L., Siracusa, G., Sorbi,
S., Federico, A., De Stefano, N., 2004. Neocortical volume decrease in relapsing-
remitting MS patients with mild cognitive impairment. Neurology 63, 89–93.
Amato, M., Zipoli, V., Portaccio, E., 2006. Multiple sclerosis-related cognitive changes: a
review of cross-sectional and longitudinal studies. J. Neurol. Sci. 245, 41–46.
Amato, M.P., Langdon, D., Montalban, X., Benedict, R.H.B., DeLuca, J., Krupp, L.B.,
Thompson, A.J., Comi, G., 2013. Treatment of cognitive impairment in multiple
sclerosis: position paper. J. Neurol. 260, 1452–1468. http://dx.doi.org/10.1007/
s00415-012-6678-0.
Aschenbrenner, A., Tucha, O., Lange, K., 2000. Regensburger wortﬂüssigkeits-test.
Handanweisung. Hogrefe Verlag, Göttingen.
Barkhof, F., 2002. The clinico-radiological paradox in multiple sclerosis revisited. Curr.
Opin. Neurol. 15, 239–245.
Barris, R.W., Schuman, H.R., 1953. Bilateral anterior cingulate gyrus lesions; syndrome of
the anterior cingulate gyri. Neurology 3, 44–52.
Benedict, R., Bruce, J.M., Dwyer, M.G., Abdelrahman, N., Hussein, S., Weinstock-Guttman,
B., Garg, N., Munschauer, F., Zivadinov, R., 2006. Neocortical atrophy, third ventricular
width, and cognitive dysfunction in multiple sclerosis. Arch. Neurol. 63, 1301–1306.
http://dx.doi.org/10.1001/archneur.63.9.1301.
Brunner, E., Munzel, U., 2000. The nonparametric Behrens–Fisher problem: asymptotic
theory and a small-sample approximation. Biom. J. 42, 17–25. http://dx.doi.org/10.
1002/(SICI)1521-4036(200001)42:1b17::AID-BIMJ17N3.0.CO;2-U.
Calabrese, P., 2006. Neuropsychology of multiple sclerosis—an overview. J. Neurol. 253
(Suppl. 1), I10–I15.
Calabrese, M., Agosta, F., Rinaldi, F., Mattisi, I., Grossi, P., Favaretto, A., Atzori, M., Bernardi,
V., Barachino, L., Rinaldi, L., Perini, P., Gallo, P., Filippi, M., 2009. Cortical lesions and
95O. Geisseler et al. / NeuroImage: Clinical 10 (2016) 89–95atrophy associated with cognitive impairment in relapsing–remitting multiple
sclerosis. Arch. Neurol. 66, 1144–1150.
Calabrese, M., Rinaldi, F., Mattisi, I., Grossi, P., Favaretto, A., Atzori, M., Bernardi, V.,
Barachino, L., Romualdi, C., Rinaldi, L., Perini, P., Gallo, P., 2010. Widespread cortical
thinning characterizes patients with MS with mild cognitive impairment. Neurology
74, 321–328.
Calabrese, M., Poretto, V., Favaretto, A., Alessio, S., Bernardi, V., Romualdi, C., Rinaldi, F.,
Perini, P., Gallo, P., 2012. Cortical lesion load associates with progression of disability
in multiple sclerosis. Brain 135, 2952–2961. http://dx.doi.org/10.1093/brain/aws246.
Chiaravalloti, N., DeLuca, J., 2008. Cognitive impairment in multiple sclerosis. Lancet
Neurol. 7, 1139–1151.
Delis, D., Kaplan, E., Kramer, J., 2001. Delis–Kaplan Executive Function System (D–KEFS).
The Psychological Corporation, San Antonio (TX).
Drew, M., Tippett, L., Starkey, N., Isler, R., 2008. Executive dysfunction and cognitive im-
pairment in a large community-based sample with multiple sclerosis from New
Zealand: a descriptive study. Arch. Clin. Neuropsychol. 23, 1–19.
Filippi, M., Rocca, M.A., 2010. MRI and cognition in multiple sclerosis. Neurol. Sci. Off.
J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol. 31, S231–S234. http://dx.doi.org/10.
1007/s10072-010-0367-5.
Fischl, B., Sereno, M.I., Dale, A., 1999. Cortical surface-based analysis: II: inﬂation, ﬂatten-
ing, and a surface-based coordinate system. NeuroImage 9, 195–207.
Flachenecker, P., König, H., Meissner, H., Müller, G., 2008. Fatigue bei Multipler Sklerose:
Validierung des “Würzburger Erschöpfungs-Inventar bei Multipler Sklerose
(WEIMuS).”. Neuro Rehabil. 14, 299–306.
Foong, J., Rozewicz, L., Quaghebeur, G., Davie, C., Kartsounis, L., Thompson, A., Miller, D.,
Ron, M., 1997. Executive function inmultiple sclerosis. The role of frontal lobe pathol-
ogy. Brain 120, 15–26.
Haid, T., Martl, C., Schubert, F., Wenzl, M., Koﬂer, M., Saltuari, L., 2002. Der “HAMASCH 5
Punkt Test” — erste Normierungsergebnisse. Z. Für Neuropsychol. 13, 233.
Hautzinger, M., Bailer, M., 1992. Allgemeine Depressionsskala ADS. Beltz Test GmbH,
Göttingen.
Henry, J.D., Beatty,W.W., 2006.Verbalﬂuencydeﬁcits inmultiple sclerosis. Neuropsychologia
44, 1166–1174.
Kidd, D., Barkhof, F., McConnell, R., Algra, P.R., Allen, I.V., Revesz, T., 1999. Cortical lesions
in multiple sclerosis. Brain 122, 17–26. http://dx.doi.org/10.1093/brain/122.1.17.
Kurtzke, J.F., 1983. Rating neurologic impairment in multiple sclerosis: an expanded
disability status scale (EDSS). Neurology 33, 1444–1452.
Lehrl, S., 2005. Mehrfachwahl–Wortschatz-intelligenz MWT-B. 5th ed. Spitta Verlag,
Balingen.
Mike, A., Strammer, E., Aradi, M., Orsi, G., Perlaki, G., Hajnal, A., Sandor, J., Banati, M., Illes,
E., Zaitsev, A., Herold, R., Guttmann, C.R.G., Illes, Z., 2013. Disconnection mechanism
and regional cortical atrophy contribute to impaired processing of facial expressions
and theory of mind in multiple sclerosis: a structural MRI study. PLoS ONE 8. http://
dx.doi.org/10.1371/journal.pone.0082422.
Morgen, K., Sammer, G., Courtney, S., Wolters, T., Melchior, H., Blecker, C., Oschmann, P.,
Kaps, M., Vaitl, D., 2006. Evidence for a direct association between cortical atrophy
and cognitive impairment in relapsing–remitting MS. Neuroimage 30, 891–898.
Morrow, S.A., Weinstock-Guttman, B., Munschauer, F.E., Hojnacki, D., Benedict, R.H.B.,
2009. Subjective fatigue is not associated with cognitive impairment in multiple scle-
rosis: cross-sectional and longitudinal analysis. Mult. Scler. 15, 998–1005. http://dx.
doi.org/10.1177/1352458509106213.
Narayana, P.A., Govindarajan, K.A., Goel, P., Datta, S., Lincoln, J.A., Coﬁeld, S.S., Cutter, G.R.,
Lublin, F.D., Wolinsky, J.S., 2013. Regional cortical thickness in relapsing remitting
multiple sclerosis: a multi-center study. NeuroImage Clin. 2, 120–131. http://dx.doi.
org/10.1016/j.nicl.2012.11.009.
Nielsen, A.S., Kinkel, R.P., Madigan, N., Tinelli, E., Benner, T., Mainero, C., 2013. Contribu-
tion of cortical lesion subtypes at 7 T MRI to physical and cognitive performance in
MS. Neurology 81, 641–649. http://dx.doi.org/10.1212/WNL.0b013e3182a08ce8.
Paus, T., 2001. Primate anterior cingulate cortex: where motor control, drive and cogni-
tion interface. Nat. Rev. Neurosci. 2, 417–424. http://dx.doi.org/10.1038/35077500.
Polman, C.H., Reingold, S.C., Banwell, B., Clanet, M., Cohen, J.A., Filippi, M., Fujihara, K.,
Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F.D., Montalban, X., O'Connor, P.,
Sandberg-Wollheim, M., Thompson, A.J., Waubant, E., Weinshenker, B., Wolinsky,
J.S., 2011. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald
criteria. Ann. Neurol. 69, 292–302. http://dx.doi.org/10.1002/ana.22366.
Radloff, L.S., 1977. The CES-D scale a self-report depression scale for research in the
general population. Appl. Psychol. Meas. 1, 385–401. http://dx.doi.org/10.1177/
014662167700100306.
Radomski, A.D., Power, C., Purdon, S.E., Emery, D.J., Blevins, G., Warren, K.G., Fujiwara, E.,
2015. Decision-making under explicit risk is impaired in multiple sclerosis:relationships with ventricular width and disease disability. BMC Neurol. 15, 61.
http://dx.doi.org/10.1186/s12883-015-0318-0.
Rao, S., Leo, G., Haughton, V., St Aubin-Faubert, P., Bernardin, L., 1989. Correlation of
magnetic resonance imaging with neuropsychological testing in multiple sclerosis.
Neurology 39, 161–166.
Rao, S., Leo, G., Ellington, L., Nauertz, T., Bernardin, L., Unverzagt, F., 1991. Cognitive
dysfunction in multiple sclerosis II. Impact on employment and social functioning.
Neurology 41, 692–696.
Regard, M., Strauss, E., Knapp, P., 1982. Children's production on verbal and non-verbal
ﬂuency tasks. Percept. Mot. Skills 55, 839–844. http://dx.doi.org/10.2466/pms.1982.
55.3.839.
Reuter, F., Zaaraoui, W., Crespy, L., Faivre, A., Rico, A., Malikova, I., Confort-Gouny, S.,
Cozzone, P.J., Ranjeva, J.-P., Pelletier, J., Audoin, B., 2011. Cognitive impairment at
the onset of multiple sclerosis: relationship to lesion location. Mult. Scler. Houndmills
Basingstoke Engl. 17, 755–758. http://dx.doi.org/10.1177/1352458511398265.
Robinson, G., Shallice, T., Bozzali, M., Cipolotti, L., 2012. The differing roles of the frontal
cortex in ﬂuency tests. Brain 135, 2202–2214. http://dx.doi.org/10.1093/brain/
aws142.
Rogers, J.M., Panegyres, P.K., 2007. Cognitive impairment in multiple sclerosis: evidence-
based analysis and recommendations. J. Clin. Neurosci. 14, 919–927.
Roosendaal, S.D., Geurts, J.J.G., Vrenken, H., Hulst, H.E., Cover, K.S., Castelijns, J.A., Pouwels,
P.J.W., Barkhof, F., 2009. Regional DTI differences in multiple sclerosis patients.
NeuroImage 44, 1397–1403. http://dx.doi.org/10.1016/j.neuroimage.2008.10.026.
Rorden, C., Karnath, H.-O., Bonilha, L., 2007. Improving lesion-symptommapping. J. Cogn.
Neurosci. 19, 1081–1088. http://dx.doi.org/10.1162/jocn.2007.19.7.1081.
Rossi, F., Giorgio, A., Battaglini, M., Stromillo, M.L., Portaccio, E., Goretti, B., Federico, A.,
Hakiki, B., Amato, M.P., De Stefano, N., 2012. Relevance of brain lesion location to cog-
nition in relapsing multiple sclerosis. PLoS ONE 7; e44826. http://dx.doi.org/10.1371/
journal.pone.0044826.
Roth, A.K., Denney, D.R., Lynch, S.G., 2015. Information processing speed and attention in
multiple sclerosis: reconsidering the Attention Network Test (ANT). J. Clin. Exp.
Neuropsychol. 1–12 http://dx.doi.org/10.1080/13803395.2015.1037252.
Sailer, M., Fischl, B., Salat, D., Tempelmann, C., Schonfeld, M., Busa, E., Bodammer, N.,
Heinze, H., Dale, A., 2003. Focal thinning of the cerebral cortex in multiple sclerosis.
Brain 126, 1734–1744.
Schwartz, S., Baldo, J., 2001. Distinct patterns of word retrieval in right and left frontal lobe
patients: a multidimensional perspective. Neuropsychologia 39, 1209–1217.
Sicotte, N., Kern, K., Giesser, B., Arshanapalli, A., Schultz, A., Montag, M., Wang, H.,
Bookheimer, S., 2008. Regional hippocampal atrophy in multiple sclerosis. Brain
131, 1134–1141.
Sperling, R.A., Guttmann, C.R., Hohol, M.J., Warﬁeld, S.K., Jakab, M., Parente, M., Diamond,
E.L., Daffner, K.R., Olek, M.J., Orav, E.J., Kikinis, R., Jolesz, F.A., Weiner, H.L., 2001.
Regional magnetic resonance imaging lesion burden and cognitive function in
multiple sclerosis: a longitudinal study. Arch. Neurol. 58, 115–121.
Stuss, D.T., Alexander, M.P., 2007. Is there a dysexecutive syndrome? Philos. Trans. R. Soc.
Lond. B Biol. Sci. 362, 901–915. http://dx.doi.org/10.1098/rstb.2007.2096.
Sumowski, J.F., Rocca, M.A., Leavitt, V.M., Dackovic, J., Mesaros, S., Drulovic, J., DeLuca, J.,
Filippi, M., 2014. Brain reserve and cognitive reserve protect against cognitive decline
over 4.5 years in MS. Neurology 82, 1776–1783. http://dx.doi.org/10.1212/WNL.
0000000000000433.
Swirsky-Sacchetti, T., Mitchell, D., Seward, J., Gonzales, C., Lublin, F., Knobler, R., Field, H.,
1992. Neuropsychological and structural brain lesions inmultiple sclerosis: a regional
analysis. Neurology 42, 1291–1295.
Tekok-Kilic, A., Benedict, R., Weinstock-Guttman, B., Dwyer, M., Carone, D.,
Srinivasaraghavan, B., Yella, V., Abdelrahman, N., Munschauer, F., Bakshi, R.,
Zivadinov, R., 2007. Independent contributions of cortical gray matter atrophy
and ventricle enlargement for predicting neuropsychological impairment in mul-
tiple sclerosis. Neuroimage 36, 1294–1300.
Van Hecke, W., Nagels, G., Leemans, A., Vandervliet, E., Sijbers, J., Parizel, P.M., 2010.
Correlation of cognitive dysfunction and diffusion tensor MRI measures in patients
with mild and moderate multiple sclerosis. J. Magn. Reson. Imaging JMRI 31,
1492–1498. http://dx.doi.org/10.1002/jmri.22198.
Zimmermann, P., Fimm, B., 2007. TAP Testbatterie zur Aufmerksamkeitsprüfung. Psytest,
Herzogenrath.
Zivadinov, R., Sepcic, J., Nasuelli, D., De Masi, R., Bragadin, L., Tommasi, M., Zambito-
Marsala, S., Moretti, R., Bratina, A., Ukmar, M., Pozzi-Mucelli, R., Grop, A., Cazzato,
G., Zorzon, M., 2001. A longitudinal study of brain atrophy and cognitive disturbances
in the early phase of relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg.
Psychiatry 70, 773–780.
